Manufacturing Chemist
  • Home
  • Categories
    • Ingredients
    • Analysis
    • Manufacturing
    • Finance
    • Company News
    • Regulatory
    • Drug Delivery
    • Research & Development
    • Sustainability
  • Pharma 5.0
  • Events
  • Directory
  • Search
    • Close search
  • Subscribe
  • Login
    • Password
      Password
      Forgot password? Close login form
  • Home
  • Company News

Company News

Cromsource expands operations and management team Cromsource expands operations and management team International contract research organisation opens new office in North America and expands executive leadership team ClinTec International expands capabilities in Spain with new offices in Madrid and Barcelona ClinTec International expands capabilities in Spain with new offices in Madrid and Barcelona Appoints Carlos Palacios as Regional Manager for Spain and Portugal Sanofi makes changes to Executive Committee Sanofi makes changes to Executive Committee Supporting the French pharmaceutical firm's 2020 Strategic Roadmap Faron strengthens executive team by appointing new Medical Director Faron strengthens executive team by appointing new Medical Director He will play a central role in expanding the Finnish firm's clinical programmes of drug candidates Vaximm appoints Dr Jarl Ulf Jungnelius as Chief Medical Officer Vaximm appoints Dr Jarl Ulf Jungnelius as Chief Medical Officer He has spent more than 30 years practising medicine and leading oncology drug development projects at pharma firms Key management changes aim to support future growth at Scancell Key management changes aim to support future growth at Scancell The firm also opens new US headquarters in San Diego Astellas names Rodrigo Fernandez as Executive Director, International Business Astellas names Rodrigo Fernandez as Executive Director, International Business Fernandez to lead Astellas' business in Latin America outside Brazil Sciformix names Fran Bates as VP of Technology Services Sciformix names Fran Bates as VP of Technology Services Appointment supports customer needs and future growth by offering technology services solutions focused on science Chief Commercial Officer appointed at Biohaven Chief Commercial Officer appointed at Biohaven John Tilton takes the newly created position at the US biopharmaceutical firm Glycotope appoints Dr Alfredo Zurlo as Chief Medical Officer Glycotope appoints Dr Alfredo Zurlo as Chief Medical Officer The company has a unique approach to the development of novel immuno-oncology candidates Dr Avinash Desai becomes VP, Americas Oncology Medical Affairs, Oncology Business Group at Eisai Inc Dr Avinash Desai becomes VP, Americas Oncology Medical Affairs, Oncology Business Group at Eisai Inc Desai has more than 20 years of experience in the oncology field New Chief Scientific Officer for AnaptysBio New Chief Scientific Officer for AnaptysBio Dr Matthew Moyle will be responsible for the discovery and early development of therapeutic antibodies generated using AnaptysBio's SHM-XEL platform Louis Yu joins AMRI as Senior Vice President, Quality and Compliance Louis Yu joins AMRI as Senior Vice President, Quality and Compliance He will oversee all aspects of quality and cGMP compliance across all divisions of AMRI AMO Pharma makes three new appointments AMO Pharma makes three new appointments All have widespread experience in the pharmaceutical industry Lumos Pharma appoints David Weiner as Chief Medical Officer Lumos Pharma appoints David Weiner as Chief Medical Officer He will steer the development of the company's rare and orphan disease therapeutics PCI Pharma Services welcomes Pieter-Jan Vos as Business Development Manager PCI Pharma Services welcomes Pieter-Jan Vos as Business Development Manager Joins the firm's international sales team Sandford Sommer joins Vernalis as President & Chief Operating Officer Sandford Sommer joins Vernalis as President & Chief Operating Officer Prior to joining the UK firm Sommer spent 24 years at AstraZeneca Edwin Klumper joins Cristal Therapeutics as Chief Medical Officer Edwin Klumper joins Cristal Therapeutics as Chief Medical Officer He will be responsible for the clinical strategy and development of Cristal Therapeutics’ nanomedicines Valeant Pharmaceuticals names Joseph Papa as Chairman and Chief Executive Valeant Pharmaceuticals names Joseph Papa as Chairman and Chief Executive He brings more than 30 years of leadership and operations experience in healthcare to the firm Paul Doody heads global marketing at Domino Printing Sciences Paul Doody heads global marketing at Domino Printing Sciences He brings a wealth of experience to the Cambridge, UK-based coding and marking specialist XenoGesis strengthens DMPK team with appointment of Peter White XenoGesis strengthens DMPK team with appointment of Peter White He specialises in mass spectrometry and bioanalysis Scottish CMO Symbiosis strengthens US presence Scottish CMO Symbiosis strengthens US presence Appoints Dr Thomas Scullion as US Business Development Manager David Lescuyer joins SkyePharma as Executive Vice President, Oral Business David Lescuyer joins SkyePharma as Executive Vice President, Oral Business He will be responsible for Skyepharma’s Oral Business including, after 30 June, the manufacturing operations in Saint-Quentin Fallavier, France Kymab hires leaders in immuno-oncology, infectious disease and blood disorders Kymab hires leaders in immuno-oncology, infectious disease and blood disorders Appointments bring internationally recognised expertise to strengthen Kymab’s key therapeutic areas
  • Previous
  • 1
  • …
  • 61
  • 62
  • 63
  • 64 (current)
  • 65
  • 66
  • 67
  • …
  • 141
  • Next

Trending Articles

  1. THX Pharma appoints Julien Veys as deputy chief executive officer Leadership appointment supports the company’s strategy to advance regulatory approval and commercialization of rare neurology therapies
  2. Kindeva announces leadership transition to support strategic growth David Stevens assumes CEO role as part of a planned succession strategy
  3. Astoriom appoints Will Edwards as Chief Executive Officer Strategic appointment to support global scale-up of sample management operations
  4. Rentschler Biopharma appoints Detra Glinatsis as head of U.S. business development Glinatsis returns to lead U.S. growth strategy and build on Milford site expansion
  5. Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO Appointment supports NanoSyrinx’s transition from platform development to clinical-stage intracellular medicines

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual
See all

Become a Subscriber

Subscribe now Already a subscriber? Sign in here. Find out more

Get our newsletter

Follow us

  • LinkedIn
  • About Manufacturing Chemist
  • About HPCi Media
  • Newsletter sign up
  • Contact Us
  • Advertise
  • Terms and Conditions
  • Privacy
© HPCi Media Limited | Registered in England No. 06716035 | VAT GB 939828072 | a Claverley Group company Registered office address:
One Anchorage Avenue,
Shrewsbury Business Park,
Shrewsbury,
SY2 6FG, UK.